International journal of cardiology
Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.
G Bonacchi, A Del Franco, P Agostoni, E Agricola, E Ammirati, P Baratta, F Barocelli, E Bertero, E Biagini, G Boriani, P Calabrò, L Calò, C Calore, S Carigi, E Carluccio
Published: 202610.1016/j.ijcard.2025.134152
Abstract
BACKGROUND: Obstructive hypertrophic cardiomyopathy (oHCM) has recently seen the introduction of mavacamten, a disease-specific therapy that alleviates obstruction and symptoms with potential effects on disease expression. Since most patients remain…
Preview only. Read the full abstract at the source